题名

Ruta graveolens as a potential source of neuroactive compounds to promote and restore neural functions

DOI

10.1016/j.jtcme.2020.05.002

作者

Luca Colucci-D'Amato;Gloria Cimaglia

关键词

Ruta graveolens ; Natural compounds ; Neural plasticity ; Neurodegeneration ; Glioblastoma

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

10卷3期(2020 / 05 / 01)

页次

309 - 314

内容语文

英文

中文摘要

Nutraceuticals had always been known for their therapeutic effects in ancient medicine and had been the primary healing remedy until the introduction of modern chemistry and pharmacology. However, their use has not been dismissed but actually is acquiring a new acclamation among the scientific community especially for their efficacy on the Central Nervous System (CNS). Molecular mechanisms of the most common neurodegenerative diseases are now being uncovered and along with that the molecules that drive the neurodegenerative processes. It is not surprising that some natural compounds can interact with those molecules and interfere with the pathological pathways halting the cascades that ultimately lead to neuronal cell death. The plant Ruta graveolens has gained increased attention in medicinal chemistry due to its beneficial role to treat a variety of human diseases and also because of the presence of a huge number of compounds belonging to different classes of natural products, including neuroactive compounds potentially able to promote neuroprotection. Among all the components of the plant extract, rutin - which is highly, if not the most, abundant - positively interacts with the neurophysiology of the CNS too, being particularly efficient against neurotoxicity. Rutin, has proven to be protective in a variety of experimental settings of neurodegeneration. Finally, it has been shown that the water extract of Ruta graveolens (RGWE) induces death of glioblastoma cells but not of neuronal cells. Moreover, it also fosters cell cycle re-entry and differentiation of neuronal cells. This peculiarity represents a promising tool to promote neural plasticity in pathological conditions.

主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. Adams, M,Gmunder, F,Hamburger, M(2007).Plants traditionally used in age related brain disorders - a survey of ethnobotanical literature.J Ethnopharmacol,113,363-381.
  2. Adsersen, A,Gauguin, B,Gudiksen, L,Jäger, AK(2006).Screening of plants used in Danish folk medicine to treat memory dysfunction for acetylcholinesterase inhibitory activity.J Ethnopharmacol,104(3),418-422.
  3. Atri, A(2019).Current and future treatments in alzheimer’s disease.Semin Neurol,39(2),227-240.
  4. Bonfanti, L(ed.)(2013).Neural Stem Cells.IntechOpen.
  5. Cao, Q,Qin, L,Huang, F(2017).Amento flavone protects dopaminergic neurons in MPTP-induced Parkinson ’ s disease model mice through PI3K/Akt and ERK signaling pathways.Toxicol Appl Pharmacol,319,80-90.
  6. Chambery, A,Colucci-D’Amato, L,Vissers, JP(2009).Proteomic Profiling of Proliferating and Differentiated Neural mes-c-myc A1 Cell Line from Mouse Embryonic Mesencephalon by LC−MS.J Proteome Res,8(1),227-238.
  7. Cimaglia, G,Gentile, MT,Pastorino, O,Colucci-D’Amato, L(2019).Ruta Graveolens Stimulates Neural Plasticity of Human and Mouse Embryonic Mesencephalic Neuronal Cell Progenitors.SfN 2019,Chicago:
  8. Colucci-D’Amato, GL,Tino, A,Pernas-Alonso, R(1999).Neu ronal and glial properties coexist in a novel mouse CNS immortalized cell line.Exp Cell Res,252(2),383-391.
  9. Colucci-D’Amato, L,di Porzio, U(2008).Neurogenesis in adult CNS: from denial to opportunities and challenges for therapy.Bioessays,30(2),135-145.
  10. Colucci-D’Amato, L,Farina, A,Vissers, JP,Chambery, A(2011).Quantitative neuro-proteomics: classical and novel tools for studying neural differentiation and function.Stem Cell Rev Rep,7(1),77-93.
  11. Cordeiro, LM,Machado, ML,da Silva, AF(2020).Rutin protects Huntington’s disease through the insulin/IGF1 (IIS) signaling pathway and autophagy activity: study in Caenorhabditis elegans model.Food Chem Toxicol,141,111323.
  12. Cui, Q,Xin, Li,Zhu, H(2016).Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.Mol Med Rep,1381-1388.
  13. Denham, A,Tobyn, G,Denham, A,Whitelegg, M.(2016).The Western Herbal Tradition: 2000 Years of Medicinal Plant Knowledge.London, UK:Singing Dragon.
  14. Di Lieto, A,Leo, D,Volpicelli, F(2007).FLUOXETINE modifies the expression of serotonergic markers in a differentiation-dependent fashion in the mesencephalic neural cell line A1 mes c-myc.Brain Res,1143,1-10.
  15. Forsatkar, MN,Hedayatirad, M,Luchiari, AC(2018)."Not tonight zebrafish": the effects of Ruta graveolens on reproduction.Pharm Biol,56(1),60-66.
  16. Fusco, FR,Anzilotti, S,Giampà, C(2012).Changes in the expression of extracellular regulated kinase (ERK 1/2) in the R6/2 mouse model of Huntington’s disease after phosphodiesterase IV inhibition.Neurobiol Dis.,46(1),225-233.
  17. Gentile, MT,Ciniglia, C,Reccia, MG,Volpicelli, F(2015).Ruta graveolens L . Induces death of glioblastoma cells and neural progenitors , but not of neurons , via ERK 1/2 and AKT activation.PloS One,2015,1-18.
  18. Gentile, MT,Nawa, Y,Lunardi, G(2012).Tryptophan hydroxylase 2 (TPH2) in a neuronal cell line: modulation by cell differentiation and NRSF/rest activity.J Neurochem,123(6),963-970.
  19. Gentile, MT,Russo, R,Pastorino, O(2018).Ruta graveolens water extract inhibits cell-cell network formation in human umbilical endothelial cells via MEKERK1/2 pathway.Exp Cell Res,364(1),50-58.
  20. Grzybowski, A,Pietrzak, K(2013).Albert Szent- Györgyi (1893-1986): the scientist who discovered vitamin C.Clin Dermatol,31(3),327-331.
  21. Guérout, N,Li, X,Barnabé-heider, F(2014).Cell fate control in the developing central nervous system.Exp Cell Res,321(1),77-83.
  22. Gutiérrez-pajares, JL,Zúñiga, L,Pino, J(2003).Ruta graveolens aqueous extract retards mouse preimplantation embryo development.Reprod Toxicol,17,667-672.
  23. Hauser, RA,Li, R,Perez, A,Ren, X(2017).Longer duration of MAO-b inhibitor exposure is associated with less clinical decline in Parkinson’s disease: an analysis of NET-PD LS1.J Parkinsons Dis,7(1),117-127.
  24. Kalra, EK(2003).Nutraceutical-definition and introduction.AAPS PharmSci,5(3),27-28.
  25. Kalra, EK,Russo, P,Frustaci, A(2013).Rutin abrogates manganese-induced striatal and hippocampal toxicity via inhibition of iron depletion, oxidative stress, inflammation and suppressing the NF-kB signaling pathway.Int J Prev Med,5(8),92-99.
  26. Kannan, R,Babu, UV(2012).Identity and pharmacognosy of Ruta graveolens linn.Ancient Sci Life,32(1),16-19.
  27. Khan, MM,Raza, SS,Javed, H(2012).Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson’s disease.Neurotox Res,22(1),1-15.
  28. Kuzovkina, I,Al’terman, I,Schneider, B(2004).Specific accumulation and revised structures of acridone alkaloid glucosides in the tips of transformed roots of Ruta graveolens.Phytochemistry,65(8),1095-1100.
  29. Lee, DY(2015).Roles of mTOR signaling in brain development.Exp Neurobiol,24(3),177-185.
  30. Li, P,Matsunaga, K,Ohizumi, Y(1999).Enhancement of the nerve growth factor-mediated neurite outgrowth from PC12D cells by Chinese and Paraguayan medicinal plants.Biol Pharm Bull,22(7),752-755.
  31. Magalingam, KB,Radhakrishnan, A,Haleagrahara, N(2013).Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity.Int J Mol Med.,32(1),235-240.
  32. Magalingam, KB,Radhakrishnan, A,Ramdas, P,Haleagrahara, N(2015).Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson’s disease.J Mol Neurosci,55(3),609-617.
  33. Mahoney, C,Feliciano, DM,Bordey, A,Hartman, NW(2016).Switching on mTORC1 induces neurogenesis but not proliferation in neural stem cells of young mice.Neurosci Lett,614,112-118.
  34. Malik, S,Moraes, DFC,do Amaral, FMM,Ribeiro, MNS(2016).Ruta graveolens: phyto-chemistry, pharmacology, and biotechnology.Transgenesis and Secondary Metabolism,Cham:
  35. Mazumder, MK,Borah, A,Choudhury, S(2020).Inhibitory potential of plant secondary metabolites on anti-parkinsonian drug targets: relevance to pathophysiology, and motor and non-motor behavioural abnormalities.Med Hypotheses,137,109544.
  36. McColgan, P,Tabrizi, SJ(2018).Huntington’s disease: a clinical review.Eur J Neurol,25(1),24-34.
  37. Naoi, M,Maruyama, W(2010).Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.Curr Pharmaceut Des.,16(25),2799-2817.
  38. Nasri, H,Baradaran, A,Shirzad, H,Rafieian-Kopaei, M(2014).New concepts in nutraceuticals as alternative for pharmaceuticals.Int J Prev Med,5(12),1487-1499.
  39. Nizzari, M,Barbieri, F,Gentile, MT(2012).Amyloid-β protein precursor regulates phosphorylation and cellular compartmentalization of microtubule associated protein tau.J Alzheimers Dis.,29(1),211-227.
  40. Nkpaa, KW,Onyeso, GI(2018).Rutin attenuates neurobehavioral deficits, oxidative stress, neuro-inflammation and apoptosis in fluoride treated rats.Neurosci Lett,682,92-99.
  41. Pan, RY,Ma, J,Kong, XX(2019).Sodium rutin ameliorates Alzheimer’s disease-like pathology by enhancing microglial amyloid-β clearance.Sci Adv.,5(2),eaau6328.
  42. Parray, S,Bhat, J,Ahmad, G,Jahan, N(2012).Ruta graveolens: from traditional system of medicine to modern pharmacology: an overview.Am J PharmTech Res,2,239-252.
  43. Pollio, A,de Natale, A,Appetitil, E,Aliotta, G,Touwaide, A(2008).Continuity and change in the Mediterranean medical tradition: ruta sp. (Rutaceae) in Hippocratic medicine and present practices.J Ethnopharmacol,116,469-482.
  44. Russo, P,Frustaci, A,Del Bufalo, A,Fini, M,Cesario, A(2013).From traditional European medicine to discovery of new drug candidates for the treatment of dementia and Alzheimer’s disease: acetylcholinesterase inhibitors.Curr Med Chem,20(8),976-983.
  45. Salem, AM,Sabry, GM,Ahmed, HH(2013).Amelioration of neuroinflammation and apoptosis characterizing Alzheimer’s disease by natural products.Int J Pharm Pharmaceut Sci.,5(SUPPL. 2),87-94.
  46. Severino, V,Farina, A,Colucci-D’Amato, L(2013).Secretome profiling of differentiated neural mes-c-myc A1 cell line endowed with stem cell properties.Biochim Biophys Acta,1834(11),2385-2395.
  47. Shojaii, A,Ghods, R,Fard, MA(2016).Medicinal herbs in Iranian traditional medicine for learning and memory.Iran J Med Sci.,41(3 suppl),S43-S43.
  48. Stafford, GI,Pedersen, ME,Van Staden, J,Jäger, AK(2008).Review on plants with CNSeffects used in traditional South African medicine against mental diseases.J Ethnopharmacol,119,513-537.
  49. Stafford, GI,Pedersen, PD,Jäger, AK,Van Staden, J(2007).Monoamine oxidase inhibition by southern African traditional medicinal plants.South Afr J Bot.,73,384-390.
  50. Suganya, SN,Sumathi, T(2017).Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington’s disease model in rats.Metab Brain Dis.,32(2),471-481.
  51. Tábi, T,Vécsei, L,Youdim, MB,Riederer, P,Szökő, É(2020).Selegiline: a molecule with innovative potential.J Neural Transm,127,831-831–842.
  52. Villa, V,Thellung, S,Corsaro, A(2016).Celecoxib inhibits prion protein 90-231-mediated pro-inflammatory responses in microglial cells.Mol Neurobiol,53(1),57-72.
  53. Wang, SW,Wang, YJ,Su, YJ(2012).Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines.Neurotoxicology,33(3),482-490.
  54. Wszelaki, N,Kuciun, A,Kiss, AK(2010).Screening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity.Acta Pharm,60(1),119-128.
  55. Wyss-Coray, T,Rogers, J(2012).Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.Cold Spring Harb Perspect Med,2(1),a006346.
  56. Xu, PX,Wang, SW,Yu, XL(2014).Rutin improves spatial memory in Alzheimer’s disease transgenic mice by reducing Ab oligomer level and attenuating oxidative stress and neuroinflammation.Behav Brain Res,264,173-180.
  57. Yamada, M,Yasuhara, H(2004).Clinical pharmacology of MAO Inhibitors : safety and future.Neurotoxicology,25,215-221.
  58. Yeung, A Wai Kan,Georgieva, MG,Atanasov, AG,Tzvetkov, NT(2019).Monoamine oxidases (MAOs) as privileged molecular targets in neuroscience: research literature analysis.Front Mol Neurosci,12,143.
  59. Yu, XL,Li, YN,Zhang, H(2015).Rutin inhibits amylin-induced neurocytotoxicity and oxidative stress.Food Funct,6(10),3296-3306.
  60. Zeng, W,Zhang, W,Lu, F,Gao, L,Gao, G(2017).Resveratrol attenuates MPP + -induced mitochondrial dysfunction and cell apoptosis via AKT/GSK-3β pathway in SN4741 cells.Neurosci Lett,637,50-56.
被引用次数
  1. Zsuzsanna Darula,Virág Demján,Tivadar Kiss,Tamás Csont,Roland Tengölics,Márton Pipicz,Imre Földesi,Gergő Szűcs,Flóra Diána Gausz,Dezső Csupor,Andrea Sója,Andrea Siska,Alexandra Fejes(2022).Stellaria media tea protects against diabetes-induced cardiac dysfunction in rats without affecting glucose tolerance.Journal of Traditional and Complementary Medicine,12(3),250-259.